Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-07 to 2025-05-08
Current total value of award: $359.2
Description: 4568228606!LORAZEPAM 2 MG/ML VIALML